| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.072 | 0.2 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |